Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Lung Research Center is a private clinical research facility based in Chesterfield, Missouri, that specializes in conducting Phase II through Phase IV clinical trials for a wide range of respiratory conditions. Established over 20 years ago and located on the campus of St. Luke's Hospital, the center provides comprehensive site services for pharmaceutical and biotechnology sponsors, including patient recruitment, trial management, and advanced pulmonary diagnostic testing. The facility is led by Principal Investigator Dr. Neil Ettinger and has contributed to the clinical development of significant therapies for Chronic Obstructive Pulmonary Disease (COPD), Idiopathic Pulmonary Fibrosis (IPF), and asthma. With an active database of over 10,000 patients and a history of participating in major trials like TORCH and UPLIFT, the center is a key regional hub for pulmonary clinical research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Lung Research Center.